is the following...
A recent trial performed in China comparing TruScreen ® with Liquid Based Cytology
and primary HPV testing demonstrated TruSreen® to have higher sensitivity than Liquid
Based Cytology for the detection of high-grade cervical precancer and cancer, and
confirmed the value of TruScreen® for population screening in China.
The test results themselves are great but I think the phrase "population screening" refers to a possible state sponsored national screening program. Which is quite outside the current distribution arrangements. I am reading between the lines but I know this has been a possibility for quite some time.
If it comes off we are all on easy street.
Cheers
from a happy holder.
the bit i like
Add PLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.5¢ |
Change
0.005(0.69%) |
Mkt cap ! $127.1M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 73.0¢ | 71.0¢ | $6.584K | 9.132K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 142225 | 1 |
View Market Depth
| Last trade - 15.40pm 10/07/2024 (20 minute delay) ? |
| PLT (ASX) Chart |